Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC RIDR-PI-103 | 2581114-71-6 | 98.0% | C27H25N7O4 | 25 MG
Supplier: Medchemexpress LLC 25MGHY144876
RIDR-PI-103 is a reactive oxygen species (ROS)-induced agent release proagent. It features a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103). It has been observed that Doxorubicin and RIDR-PI-103 exhibit a synergistic effect in MDA-MB-361 and MDA-MB-231 cells, leading to the inhibition of cancer cell proliferation. This product is intended for research use only.
- Reactive oxygen species (ROS)-induced agent release proagent
- Features a self-cyclizing moiety linked to a pan-PI3K inhibitor (PI-103)
- Exhibits synergistic effect with Doxorubicin in MDA-MB-361 and MDA-MB-231 cells to inhibit cancer cell proliferation
- Targets reactive oxygen species
- Targets immunology/inflammation pathway
- Targets metabolic enzyme/protease pathway
- Targets NF-κB pathway
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?